|
Private label segment ripe for innovation at chain drug stores.
From:
Chain Drug Review
| Date:
November 21, 1994
| COPYRIGHT 1994 Racher Press, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group.Copyright information
|
NEW YORK -- The chain drug industry is on the verge of taking private label products to a new plateau. Having established store brands as quality lines, the trade class can use the products to entice consumers with whole new categories, says Private Label Manufacturers Association president Brian Sharoff.
"After about 10 years of watching drug chains battle very aggressively for respect for their private label lines, they are now poised for a new level of development," he cl...
Related newspaper, magazine, and journal articles from HighBeam Research
|
Exclusives enhance H&BA arena.(STORE BRANDS)(Private Label Manufacturers Association)(Industry Overview)
MMR
; NEW YORK -- Private label products are playing a more important role in chain drug stores than ever, with retailers continuing to add new items. Walgreen Co., for instance, recently debuted the Dr. Jan Adams Women of Color Total Skin Care System, a five-item line for women with dark skin tones.
|
|
Private label products seen playing bigger part in market. (over-the-counter drugs) (Industry Overview)
Chain Drug Review
; NEW YORK--Though the private label business is enjoying unprecedented success, at least one industry observer says that its best days are still ahead. I feel that by the turn of the century we may be looking at a 40% to 50% share for private label products in unit sales, says Herbert Shuster, a
|
|
PLMA study tracks growing strength of store brand items. (Private Label Manufacturers Association)(Private Label Report)(Industry Overview)
Chain Drug Review
; NEW YORK - There are few national brands that have had the kind of across-the-board growth generated by private label products in all classes of trade. With the category growing to $37 billion in sales last year, store brands have never been as strong a force in mass market retailing as they are
|
|
Private label segment ripe for innovation at chain drug stores.
Chain Drug Review
; NEW YORK -- The chain drug industry is on the verge of taking private label products to a new plateau. Having established store brands as quality lines, the trade class can use the products to entice consumers with whole new categories, says Private Label Manufacturers Association president Brian
|
|
PL momentum rises; market share gains. (Merchandising).(private label bath and fragrance products)
MMR
; NEW YORK -- Consumer acceptance of private label cosmetics, bath and fragrance items has enabled store brand versions of these products to maintain significant penetration in their respective categories. According to data compiled by Information Resources Inc. (IRI), sales of private label women's
|